Measurement and Accurate Interpretation of the Solubility of Pharmaceutical Salts

被引:33
作者
He, Yan [1 ]
Ho, Chris [1 ]
Yang, Donglai [1 ]
Chen, Jeane [1 ]
Orton, Edward [2 ]
机构
[1] Sanofi, Predev Sci, Waltham, MA 02451 USA
[2] Prescient Drug Delivery LLC, Berkeley Hts, NJ 07922 USA
关键词
salt; solubility; pH; dissolution; poorly water soluble; solution phase; solid phase; equilibrium; salt dissociation; phase-transformation; WEAKLY BASIC DRUG; DISSOLUTION RATE; HCL SALT; PH; SELECTION; WATER; DISPROPORTIONATION; FORMULATION; VALIDATION; CONVERSION;
D O I
10.1016/j.xphs.2017.01.023
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Salt formation is one of the primary approaches to improve the developability of ionizable poorly water-soluble compounds. Solubility determination of the salt candidates in aqueous media or biorelevant fluids is a critical step in salt screening. Salt solubility measurements can be complicated due to dynamic changes in both solution and solid phases. Because of the early implementation of salt screening in research, solubility measurements often are performed using minimal amount of material. Some salts have transient high solubility on dissolution. Recognition of these transients can be critical in developing these salts into drug products. This minireview focuses on challenges in salt solubility measurements due to the changes in solution caused by self-buffering effects of dissolved species and the changes in solid phase due to solid-state phase transformations. Solubility measurements and their accurate interpretation are assessed in the context of dissolution monitoring and solid-phase analysis technologies. A harmonized method for reporting salt solubility measurements is recommended to reduce errors and to align with the U.S. Pharmacopeial policy and Food and Drug Administration recommendations for drug products containing pharmaceutical salts. (C) 2017 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1190 / 1196
页数:7
相关论文
共 55 条
  • [1] A miniaturized in vitro release method for investigating drug-release mechanisms
    Ahnfelt, E.
    Sjogren, E.
    Axen, N.
    Lennernas, H.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 486 (1-2) : 339 - 349
  • [2] PREDICTIVE RELATIONSHIPS IN THE WATER SOLUBILITY OF SALTS OF A NONSTEROIDAL ANTI-INFLAMMATORY DRUG
    ANDERSON, BD
    CONRADI, RA
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (08) : 815 - 820
  • [3] Interlaboratory Validation of Small-Scale Solubility and Dissolution Measurements of Poorly Water-Soluble Drugs
    Andersson, Sara B. E.
    Alvebratt, Caroline
    Bevernage, Jan
    Bonneau, Damien
    Mathews, Claudia da Costa
    Dattani, Rikesh
    Edueng, Khadijah
    He, Yan
    Holm, Rene
    Madsen, Cecilie
    Mueller, Thomas
    Muenster, Uwe
    Mullertz, Anette
    Ojala, Krista
    Rades, Thomas
    Sieger, Peter
    Bergstrom, Christel A. S.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (09) : 2864 - 2872
  • [4] [Anonymous], 2015, FDA GUIDANCE IND NAM
  • [5] [Anonymous], 2013, USP SALT POLICY FDA
  • [6] Miniaturized rotating disk intrinsic dissolution rate measurement: Effects of buffer capacity in comparisons to traditional Wood's apparatus
    Avdeef, Alex
    Tsinman, Oksana
    [J]. PHARMACEUTICAL RESEARCH, 2008, 25 (11) : 2613 - 2627
  • [7] Solubility of sparingly-soluble ionizable drugs
    Avdeef, Alex
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 568 - 590
  • [8] Suggested Improvements for Measurement of Equilibrium Solubility-pH of Ionizable Drugs
    Avdeef, Alex
    [J]. ADMET AND DMPK, 2015, 3 (02): : 84 - 109
  • [9] Avdeef Alex, 1998, Pharmacy and Pharmacology Communications, V4, P165
  • [10] Salt selection and optimisation procedures for pharmaceutical new chemical entities
    Bastin, RJ
    Bowker, MJ
    Slater, BJ
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2000, 4 (05) : 427 - 435